Clinical Laboratory Services that help reduce your timeline and costs in getting more effective cancer treatment drugs to the patient and the marketplace.

Oncology Research Therapeutics (ORT) Inc. offers the following cancer treatment drug development services to pharmaceutical companies:
Examine Your current drugs on 'Gold-Standard' in-vitro protocols
Examine Your current drugs off 'Gold-Standard' in-vitro protocols
Examine Your 'Pipeline' drugs using in-vitro protocols

ORT is also building a series of proprietary databanks:
Statistical data in the ORT in-vitro Statistical CRSA Assay Databank™
Tissue data in the ORT in-vitro Tissue CSRA Assay Databank™
In-vivo statistical data in the ORT in-vivo Statistical CSRA Assay Databank™.
Contact ORT For Your Database Access Key

ORT Inc., has proven its ability to speed identification of lead compounds and new tumor targets through its in-vitro human tumor studies. Our products and services help reduce your development costs, by improving the lead to market timeline, and increase your profitability, by extension of product lifecycle.